|
gptkbp:instanceOf
|
gptkb:company
gptkb:government_agency
|
|
gptkbp:businessModel
|
gptkb:public_company
|
|
gptkbp:CEO
|
gptkb:Richard_Scott
|
|
gptkbp:collaboratesWith
|
gptkb:NHS_England
gptkb:Illumina
gptkb:Genomics_Health_Alliance
gptkb:Wellcome_Sanger_Institute
|
|
gptkbp:country
|
gptkb:United_Kingdom
|
|
gptkbp:dataSource
|
gptkb:National_Genomic_Research_Library
|
|
gptkbp:focus
|
gptkb:cancer
genomic medicine
rare diseases
|
|
gptkbp:foundedBy
|
gptkb:UK_Department_of_Health
|
|
gptkbp:foundedYear
|
2013
|
|
gptkbp:headquartersLocation
|
gptkb:London
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Genomics England
|
|
gptkbp:industry
|
genomics
healthcare
|
|
gptkbp:legalStatus
|
wholly owned by the UK Department of Health and Social Care
|
|
gptkbp:mission
|
to sequence 100,000 whole genomes from NHS patients
|
|
gptkbp:notableProject
|
gptkb:100,000_Genomes_Project
|
|
gptkbp:numberOfEmployees
|
over 200
|
|
gptkbp:parentOrganization
|
Department of Health and Social Care
|
|
gptkbp:website
|
https://www.genomicsengland.co.uk/
|
|
gptkbp:bfsParent
|
gptkb:Wellcome_Trust_Sanger_Institute
gptkb:Sir_John_Bell
|
|
gptkbp:bfsLayer
|
5
|